Download PDF
Thromb Haemost 1966; 15(03/04): 519-538
DOI: 10.1055/s-0038-1649455
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

A Re-Appraisal of the Role of Blood Coagulation and Platelets in the Generalized Shwartzman Phenomenon[*]

J Levin
1   Department of Medicine of The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland
,
E Beck
1   Department of Medicine of The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

The role of intravascular coagulation in the production of the generalized Shwartzman phenomenon has been evaluated. The administration of endotoxin to animals prepared with Thorotrast results in activation of the coagulation mechanism with the resultant deposition of fibrinoid material in the renal glomeruli. Anticoagulation prevents alterations in the state of the coagulation system and inhibits development of the renal lesions. Platelets are not primarily involved. Platelet antiserum produces similar lesions in animals prepared with Thorotrast, but appears to do so in a manner which does not significantly involve intravascular coagulation.

The production of adrenal cortical hemorrhage, comparable to that seen in the Waterhouse-Friderichsen syndrome, following the administration of endotoxin to animals that had previously received ACTH does not require intravascular coagulation and may not be a manifestation of the generalized Shwartzman phenomenon.

* This work was supported by grants from the National Institutes of Health, Bethesda, and by contracts with the Army Biological Laboratory and the Atomic Energy Commission.


 

  • References

  • 1 Bennett Jr I. L., Cluff L. E. Bacterial pyrogens. Pharm. Rev 09: 427 1957;
    PubMedGoogle Scholar
  • 2 Lee L. Antigen-antibody reaction in the pathogenesis of bilateral renal cortical necrosis. J. exp. Med 117: 365 1963;
    CrossrefPubMedGoogle Scholar
  • 3 Horowitz H. I, Des Prez R. M, Hook E. W. Effects of bacterial endotoxin on rabbit platelets. II. Enhancement of platelet factor 3 activity in vitro and in vivo. J. exp. Med 116: 619 1962;
    PubMedGoogle Scholar
  • 4 McKay D. G, Shapiro S. S. Alterations in the blood coagulation system induced by bacterial endotoxin. I. In vivo (generalized Shwartzman reaction). J. exp. Med 107: 353 1958;
    PubMedGoogle Scholar
  • 5 Biggs R, Macjarlane R. G. Human Blood Coagulation and Its Disorders. 3rd ed. 74 258 F.A. Davis Co; Philadelphia: 1962
    Google Scholar
  • 6 Robbins J, Stetson C. A. An effect of antigen-antibody interaction on blood coagulation. J. exp. Med 109: 1 1959;
    CrossrefPubMedGoogle Scholar
  • 7 Robbins B, Collins R. D. Studies on the Shwartzman reaction. Production of the renal lesions by intra-aortic infusion of thrombin. Fed. Proc 20: 261 1961;
    PubMedGoogle Scholar
  • 8 Lee L. Reticuloendothelial clearance of circulating fibrin in the pathogenesis of the generalized Shwartzman reaction. J. exp. Med 115: 1065 1962;
    CrossrefPubMedGoogle Scholar
  • 9 Cluff L. E, Berthrong M. The inhibition of the local Shwartzman reaction by heparin. Bull. Johns Hopk. Hosp 92: 353 1953;
    PubMedGoogle Scholar
  • 10 Good R. A, Thomas L. Studies on the generalized Shwartzman reaction. IV. Prevention of the local and generalized Shwartzman reactions with sodium warfarin. J. exp. Med 97: 871 1953;
    PubMedGoogle Scholar
  • 11 Shapiro S. S, McKay D. G. The prevention of the generalized Shwartzman reaction with sodium warfarin. J. exp. Med 107: 377 1958;
    CrossrefPubMedGoogle Scholar
  • 12 Kliman A, McKay D. G. The prevention of the generalized Shwartzman reaction by fibrinolytic activity. Arch. Path 66: 715 1958;
    PubMedGoogle Scholar
  • 13 Lee L, McCluskey R. T. Immunohistochemical demonstration of the reticuloendothelial clearance of circulating fibrin aggregates. J. exp. Med 116: 611 1962;
    CrossrefPubMedGoogle Scholar
  • 14 Pappas G. D, Ross M. H, Thomas L. Studies on the generalized Shwartzman reaction. VIII. The appearance, by electron microscopy, of intravascular fibrinoid in the glomerular capillaries during the reaction. J. exp. Med 107: 333 1958;
    PubMedGoogle Scholar
  • 15 Vazquez J. J, Dixon F. J. Immunohistochemical analysis of lesions associated with “fibrinoid change”. Arch. Path 66: 504 1958;
    PubMedGoogle Scholar
  • 16 McKay D. G, Gitlin D, Craig J. M. Immunochemical demonstration of fibrin in the generalized Shwartzman reaction. Arch. Path 67: 270 1959;
    PubMedGoogle Scholar
  • 17 Kleinmaier H, Goergen K, Lasch H. G, Krecke H. J, Bohle A. Untersuchungen zur Frage der Gerinnungsstörung beim Sanarelh-Shwartzman-Phänomen (sog. generalisiertes Shwartzman-Phänomen) des Kaninchens. Z. ges. exp. Med 132: 275 1959;
    CrossrefPubMedGoogle Scholar
  • 18 Stetson C. A. Studies on the mechanism of the Shwartzman phenomenon. Certain factors involved in the production of the local hemorrhagic necrosis. J. exp. Med 93: 489 1951;
    PubMedGoogle Scholar
  • 19 Levin J, Cluff L. E. Platelets and the Shwartzman phenomenon. J. exp. Med 121: 235 1965;
    CrossrefPubMedGoogle Scholar
  • 20 McKay D. G, Shapiro S. S, Shaneberge J. N. Alterations in the blood coagulation system induced by bacterial endotoxins. II. In vitro. J. exp. Med 107: 369 1958;
    PubMedGoogle Scholar
  • 21 Des Prez R. M, Horowitz H. I, Hook E. W. Effects of bacterial endotoxin on rabbit platelets. I. Platelet aggregation and release of platelet factors in vitro. J. exp. Med 114: 857 1961;
    PubMedGoogle Scholar
  • 22 Stetson C. A, Good R. A. Studies on the mechanism of the Shwartzman phenomenon. Evidence for the participation of polymorphonuclear leucocytes in the phenomenon. J. exp. Med 93: 49 1951;
    PubMedGoogle Scholar
  • 23 Good R. A, Thomas L. Studies on the generalized Shwartzman phenomenon. II. The production of bilateral cortical necrosis of the kidneys by a single injection of bacterial toxin in rabbits previously treated with thorotrast or trypan blue. J. exp. Med 96: 625 1952;
    PubMedGoogle Scholar
  • 24 Levin J, Cluff L. E. Endotoxemia and adrenal hemorrhage: A mechanism for the Waterhouse-Friderichsen syndrome. J. exp. Med 121: 247 1965;
    CrossrefPubMedGoogle Scholar
  • 25 Michaelis L. Der Acetat-Veronal-Puffer. Biochem. Z 234: 139 1931;
    PubMedGoogle Scholar
  • 26 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta haemat. (Basel.) 17: 237 1957;
    CrossrefPubMedGoogle Scholar
  • 27 Rcitnoff O. D, Menzie C. A new Method for the determination of fibrinogen in small samples of plasma. J. Lab. clin. Med 37: 316 1951;
    PubMedGoogle Scholar
  • 28 Brambel C. E. Thromboplastic reagent. Arch. Surg 50: 137 1945;
    CrossrefPubMedGoogle Scholar
  • 29 Koller F, Loeliger A, Duckert F. Experiments on a new clotting factor (factor VII). Acta haemat. (Basel.) 06: 1 1955;
    PubMedGoogle Scholar
  • 30 von Kaulla K. N. Chemistry of Thrombolysis. Human Fibrinolytic Enzymes. 79 Thomas; Springfield: 1963
    Google Scholar
  • 31 Brecher G, Cronkite E. P. Morphology and enumeration of human blood platelets. J. appl. Physiol 03: 365 1950;
    CrossrefPubMedGoogle Scholar
  • 32 Richcar W. J, Breakall E. S. Evaluation of an electronic particle counter for the counting of white blood cells. Amer. J. clin. Path 31: 384 1959;
    PubMedGoogle Scholar
  • 33 Thomas L, Smith R. T, von Korff R. Studies on the generalized Shwartzman reaction. VII. The role of fibrinogen in the deposition of fibrinoid after combined injections of endotoxin and synthetic acidic polymer. J. exp. Med 102: 263 1955;
    PubMedGoogle Scholar
  • 34 Duckert F. Diagnostic différentiel de la coagulation intravaseulaire et de la fibrinolyse. Schweiz, med. Wschr 94: 1375 1964;
    PubMedGoogle Scholar
  • 35 Jackson D. P, Hartmann R. C, Busby T. Fibrinogenopenia complicating pregnancy. Clinical and laboratory studies. Obstet, and Gynec 05: 223 1955;
    PubMedGoogle Scholar
  • 36 Schmid H. J, Jackson P, Conley C. L. Mechanism of action of thrombin on platelets. J. clin. Invest 41: 543 1962;
    CrossrefPubMedGoogle Scholar
  • 37 Antopol W, Chryssanthou C. Shwartzman phenomenon : newer concepts. Arch. Path 78: 313 1964;
    PubMedGoogle Scholar
  • 38 Haustein K-O, Markwardt F. Über den Einfluß von Hemmstoffen der Blutgerinnung und Fibrinolyse auf das Sanarelli-Shwartzman-Phänomen. Thrombos. Diathes. haemorrh. (Stuttg.) 13: 60 1965;
    PubMedGoogle Scholar
  • 39 Horowitz H. I. The effect of bacterial endotoxins on blood coagulation. Hémostase 04: 43 1964;
    PubMedGoogle Scholar
  • 40 Weber E, Malessa S, Lasch H. G. Veränderungen der freien Thrombozytennukleotide beim Sanarelh-Shwartzman-Phänomen. Thrombos. Diathes. haemorrh. (Stuttg.) 09: 304 1963;
    PubMedGoogle Scholar
  • 41 Thomas L, Good R. A. The effect of cortisone on the Shwartzman reaction. The production of lesions resembling the dermal and generalized Shwartzman reactions by a single injection of bacterial toxin in cortisone-treated rabbits. J. exp. Med 95: 409 1952;
    PubMedGoogle Scholar